Geneos Wealth Management’s First Trust Large Cap Value AlphaDEX Fund FTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.7K | Hold |
300
| – | – | ﹤0.01% | 1653 |
|
|
2025
Q4 | $25.8K | Hold |
300
| – | – | ﹤0.01% | 1637 |
|
|
2025
Q3 | $25K | Hold |
300
| – | – | ﹤0.01% | 1642 |
|
|
2025
Q2 | $23.6K | Sell |
300
-322
| -52% | -$24.1K | ﹤0.01% | 1953 |
|
|
2025
Q1 | $47.7K | Buy |
622
+267
| +75% | +$20.7K | ﹤0.01% | 1944 |
|
|
2024
Q4 | $27.1K | Sell |
355
-4
| -1% | -$318 | ﹤0.01% | 1588 |
|
|
2024
Q3 | $28.4K | Buy |
359
+59
| +20% | +$4.51K | ﹤0.01% | 1416 |
|
|
2024
Q2 | $22.1K | Hold |
300
| – | – | ﹤0.01% | 1314 |
|
|
2024
Q1 | $22.9K | Sell |
300
-46
| -13% | -$3.3K | ﹤0.01% | 1313 |
|
|
2023
Q4 | $24.5K | Sell |
346
-88
| -20% | -$5.82K | ﹤0.01% | 1287 |
|
|
2023
Q3 | $28.1K | Hold |
434
| – | – | ﹤0.01% | 1261 |
|
|
2023
Q2 | $28.9K | Buy |
434
+134
| +45% | +$8.71K | ﹤0.01% | 1255 |
|
|
2023
Q1 | $19.9K | Hold |
300
| – | – | ﹤0.01% | 1349 |
|
|
2022
Q4 | $19.7K | Sell |
300
-1,063
| -78% | -$69K | ﹤0.01% | 1340 |
|
|
2022
Q3 | $78K | Buy |
1,363
+1,063
| +354% | +$68.3K | 0.01% | 868 |
|
|
2022
Q2 | $18K | Hold |
300
| – | – | ﹤0.01% | 1727 |
|
|
2022
Q1 | $21K | Hold |
300
| – | – | ﹤0.01% | 1780 |
|
|
2021
Q4 | $20K | Hold |
300
| – | – | ﹤0.01% | 1887 |
|
|
2021
Q3 | $19K | Hold |
300
| – | – | ﹤0.01% | 1937 |
|
|
2021
Q2 | $19K | Hold |
300
| – | – | ﹤0.01% | 1938 |
|
|
2021
Q1 | $19K | Hold |
300
| – | – | ﹤0.01% | 2107 |
|
|
2020
Q4 | $19K | Hold |
300
| – | – | ﹤0.01% | 1940 |
|
|
2020
Q3 | $13K | Hold |
300
| – | – | ﹤0.01% | 1854 |
|
|
2020
Q2 | $13K | Hold |
300
| – | – | ﹤0.01% | 1802 |
|
|
2020
Q1 | $11K | Sell |
300
-200
| -40% | -$9.94K | ﹤0.01% | 1768 |
|
|
2019
Q4 | $28K | Hold |
500
| – | – | ﹤0.01% | 1536 |
|
|
2019
Q3 | $25K | Buy |
500
+300
| +150% | +$15.4K | ﹤0.01% | 1506 |
|
|
2019
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 1904 |
|
|
2019
Q1 | $10K | Hold |
200
| – | – | ﹤0.01% | 1838 |
|
|
2018
Q4 | $9K | Hold |
200
| – | – | ﹤0.01% | 1817 |
|
|
2018
Q3 | $10K | Hold |
200
| – | – | ﹤0.01% | 1840 |
|
|
2018
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 1717 |
|
|
2018
Q1 | $10K | Hold |
200
| – | – | ﹤0.01% | 1643 |
|
|
2017
Q4 | $10K | Hold |
200
| – | – | ﹤0.01% | 1630 |
|
|
2017
Q3 | $10K | Sell |
200
-868
| -81% | -$43.7K | ﹤0.01% | 1570 |
|
|
2017
Q2 | $53K | Buy |
1,068
+868
| +434% | +$43K | 0.01% | 898 |
|
|
2017
Q1 | $9K | Hold |
200
| – | – | ﹤0.01% | 1517 |
|
|
2016
Q4 | $9K | Hold |
200
| – | – | ﹤0.01% | 1455 |
|
|
2016
Q3 | $8K | Sell |
200
-1,811
| -90% | -$76K | ﹤0.01% | 1440 |
|
|
2016
Q2 | $80K | Sell |
2,011
-3,600
| -64% | -$145K | 0.01% | 650 |
|
|
2016
Q1 | $227K | Buy |
+5,611
| New | +$210K | 0.03% | 406 |
|
Other funds holding FTA
IWC
Geneos Wealth Management's FTA Position: Q1 2026 in Review
Geneos Wealth Management held its First Trust Large Cap Value AlphaDEX Fund (FTA) position steady in Q1 2026 at 300 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1653.
Geneos Wealth Management first reported a position in FTA in Q1 2016 and has held it in 41 quarters since. The position peaked at $227K in Q1 2016. 218 funds tracked by Wall St. Rank hold FTA as of Q1 2026.
- Geneos Wealth Management held 300 shares of First Trust Large Cap Value AlphaDEX Fund worth $27.7K as of Q1 2026.
- Geneos Wealth Management left its First Trust Large Cap Value AlphaDEX Fund share count unchanged in Q1 2026.
- First Trust Large Cap Value AlphaDEX Fund made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1653 holding.
- Geneos Wealth Management first reported a position in First Trust Large Cap Value AlphaDEX Fund in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's First Trust Large Cap Value AlphaDEX Fund position peaked at $227K in Q1 2016.
- 218 funds tracked by Wall St. Rank held First Trust Large Cap Value AlphaDEX Fund as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.